<code id='10F491D7A9'></code><style id='10F491D7A9'></style>
    • <acronym id='10F491D7A9'></acronym>
      <center id='10F491D7A9'><center id='10F491D7A9'><tfoot id='10F491D7A9'></tfoot></center><abbr id='10F491D7A9'><dir id='10F491D7A9'><tfoot id='10F491D7A9'></tfoot><noframes id='10F491D7A9'>

    • <optgroup id='10F491D7A9'><strike id='10F491D7A9'><sup id='10F491D7A9'></sup></strike><code id='10F491D7A9'></code></optgroup>
        1. <b id='10F491D7A9'><label id='10F491D7A9'><select id='10F491D7A9'><dt id='10F491D7A9'><span id='10F491D7A9'></span></dt></select></label></b><u id='10F491D7A9'></u>
          <i id='10F491D7A9'><strike id='10F491D7A9'><tt id='10F491D7A9'><pre id='10F491D7A9'></pre></tt></strike></i>

          fashion

          fashion

          author:explore    Page View:5
          Tome cofounders Jonathan Gootenberg, left, and Omar Abudayyeh, a scientific team that's trying to reinvent gene editing for a new era of biotech innovation.
          Suzanne Kreiter/Globe staff

          WATERTOWN — Their brainstorming began in an MIT class in 2010 when the eager undergrads shot each other emails about how to solve a bioengineering equation. It has continued for 14 years over sushi dinners, between Marvel movies, and during rowing-machine workouts.

          Together, Omar Abudayyeh, 33, and Jonathan Gootenberg, 32, have probed the mysteries of genomic editing and COVID detection. They co-published 10 scientific papers, helped launch two medical-diagnostic companies, and cofounded a Watertown startup, Tome Biosciences, that reengineers genes and cells to cure diseases. They also run the Abudayyeh-Gootenberg Lab at Harvard.

          advertisement

          Gootenberg and Abudayyeh are an unusual pair, two scientists — a Jewish American and a Palestinian American — who prefer working together in a field that often draws solitary researchers and rewards individual achievement.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          comprehensive

          Drug repurposing or repositioning? The language matters
          Drug repurposing or repositioning? The language matters

          AdobeFindinganewmedicineisnevereasy.Butdevelopingtreatmentsforpatientswithrarediseases—conditionstha

          read more
          How digital tools helped lower hypertension in marginalized patients
          How digital tools helped lower hypertension in marginalized patients

          Digitaltoolstobettertrackbloodpressureovertimeandencourageadherencetotreatmentplansareincreasinglyco

          read more
          How one medical school became remarkably diverse
          How one medical school became remarkably diverse

          ThefirstclassattheUniversityofCalifornia,Davismedicalschool,in1972,waspredominantlywhiteandmale.Chri

          read more

          Gene editing the human germline: What are the risks?

          Germlineeditingcanbeusedtorepairadefectivegeneinaspermcell.APStockGeneeditingholdsgreatpromisefortre